← 홈

Antibody

168개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 168개
AntibodystaleTianjin Medical University Canc…Phase 2

trastuzumab (Herceptin, pyrotinib + trastuzumab + nab-paclitaxel)

HER2+ Early or Locally Advanced Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, pyrotinib and trastuzumab in combinition with neoadjuvant chemotherapy)

HER2-positive Breast Cancer; Neoadjuvant Therapy · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleJiangsu Hengrui Pharmaceutical …Phase 2

trastuzumab (Herceptin, pyrotinib combined with trastuzumab, dalpiciclib and letrozole)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

H (trastuzumab, trastuzumab (H))

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, trastuzumab derxutecan)

Breast Cancer Metastatic; Breast Cancer Stage IV · Breast Cancer Metastatic

#BreastCancerMetastatic#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

trastuzumab (Herceptin, trastuzumab emtansin)

Early-Stage Breast Carcinoma; HER-2 Positive Breast Cancer · Early-Stage Breast Carcinoma

#Early-StageBreastCarcinoma#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleRochePreclinical

trastuzumab (Herceptin, Henlius®, trastuzumab(Henlius®) combined with Pertuzumab(Perjeta®) and Chemotherapy)

HER2-positive Metastatic Breast Cancer; Previously Treated With Trastuzumab · HER2

#HER2#Antibody#Preclinical#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, vinorelbine and trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING

9 / 9 페이지

← 이전다음 →